🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Chronic obstructive pulmonary disease (COPD) is one of the commonest respir...
Status
Completed
Location
Beijing Chao-Yang Hospital
Start Date
2011-11
Trial ID
NCT01455129
Treatments Being Tested
To demonstrate that tiotropium (Spiriva®) does not prolong the QT interval ...
Status
Completed
Location
Humanpharmakologisches Zentrum
Start Date
2004-10
Trial ID
NCT00257452
Treatments Being Tested
GSK233705 is a high-affinity specific muscarinic receptor (mAChR) antagonis...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-12-12
Trial ID
NCT00279019
Treatments Being Tested
The trial is a randomised, double-blind, placebo-controlled, parallel-group...
Status
Completed
Location
205.416.01007 Boehringer Ingelheim Investigational Site
Start Date
2008-10
Trial ID
NCT00772538
Treatments Being Tested
To demonstrate the efficacy of inhaled tiotropium + olodaterol via Respimat...
Status
Completed
Location
SEC Lung
Start Date
2020-01-08
Trial ID
NCT04223843
Treatments Being Tested
The primary purpose of this study is to evaluate lung function and health r...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-06-25
Trial ID
NCT03478696
The primary objective of this trial is to evaluate the safety and efficacy ...
Status
Completed
Location
205.443.12003 Boehringer Ingelheim Investigational Site
Start Date
2012-07
Trial ID
NCT01634113
Treatments Being Tested
The purpose of this study is to evaluate discontinuation rates of roflumila...
Status
Completed
Location
Multiple Locations
Start Date
2014-05-01
Trial ID
NCT02165826
Treatments Being Tested
The primary objective of this trial is to investigate the effect of 6 weeks...
Status
Completed
Location
1237.14.01404 Boehringer Ingelheim Investigational Site
Start Date
2012-02
Trial ID
NCT01533935
Treatments Being Tested
The overall objective of this study is to assess efficacy and safety of 12 ...
Status
Completed
Location
1222.52.02090 Boehringer Ingelheim Investigational Site
Start Date
2012-09
Trial ID
NCT01696058
Treatments Being Tested